Tal Zaks, Moderna CMO (AP Photo/Rodrique Ngowi, via still image from video)
CMO Tal Zaks bids Moderna a surprise adieu as biotech projects $18.4B in revenue, plots post-Covid expansion
How do you exit a company after six years in style? Developing one of the most lucrative and life-saving products in pharma history is probably …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
